Landscape of Germline Genetic Variants in AGT, MGMT, and TP53 in Mexican Adult Patients with Astrocytoma

被引：4

作者：

Alberto Carlos-Escalante, Jose ^{[1
]}

Gomez-Flores-Ramos, Liliana ^{[2
]}

Bian, Xiaopeng ^{[3
]}

Perdomo-Pantoja, Alexander ^{[4
]}

de Andrade, Kelvin Cesar ^{[5
]}

Liana Mejia-Perez, Sonia ^{[6
,7
]}

Cacho-Diaz, Bernardo ^{[8
]}

Gonzalez-Barrios, Rodrigo ^{[9
]}

Reynoso-Noveron, Nancy ^{[9
]}

Soto-Reyes, Ernesto ^{[10
]}

Estefania Sanchez-Correa, Thalia ^{[7
]}

Guerra-Calderas, Lissania ^{[10
]}

Yan, Chunhua ^{[3
]}

Chen, Qingrong ^{[3
]}

Castro-Hernandez, Clementina ^{[11
]}

Vidal-Millan, Silvia ^{[12
]}

Taja-Chayeb, Lucia ^{[9
]}

Gutierrez, Olga ^{[9
]}

Maria Alvarez-Gomez, Rosa ^{[12
]}

Luis Gomez-Amador, Juan ^{[7
]}

Ostrosky-Wegman, Patricia ^{[13
]}

Mohar-Betancourt, Alejandro ^{[11
]}

Alonso Herrera-Montalvo, Luis ^{[11
,14
]}

Corona, Teresa ^{[15
]}

Meerzaman, Daoud ^{[3
]}

Wegman-Ostrosky, Talia ^{[9
]}

机构：

[1] Univ Nacl Autonoma Mexico, Fac Med, PECEM MD PhD, Mexico City, DF, Mexico

[2] Catedras CONACYT Inst Nacl Salud Publ, Cuernavaca 62100, Morelos, Mexico

[3] NCI, Computat Genom & Bioinformat Grp, Ctr Biomed Informat & Informat Technol, NIH, Rockville, MD 20850 USA

[4] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA

[5] NCI, Clin Genet Branch, Div Canc Epidemiol & Genet, NIH, Rockville, MD 20850 USA

[6] Inst Nacl Neurol & Neurocirugia Manuel Velasco Su, Dept Ensenanza, Mexico City 13269, DF, Mexico

[7] Inst Nacl Neurol & Neurocirugia Manuel Velasco Su, Dept Neurocirugia, Mexico City 14269, DF, Mexico

[8] Inst Nacl Cancerol, Unidad Neurociencia, Mexico City 14080, DF, Mexico

[9] Inst Nacl Cancerol, Direcc Invest, Mexico City 14080, DF, Mexico

[10] Univ Autonoma Metropolitana Cuajimalpa, Dept Ciencias Nat, Mexico City 05370, DF, Mexico

[11] UNAM INCAN, Inst Invest Biomed, Unidad Epidemiol & Invest Biomed Canc, Mexico City 14080, DF, Mexico

[12] Inst Nacl Cancerol, Clin Canc Hereditario, Mexico City 14080, DF, Mexico

[13] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City 04510, DF, Mexico

[14] Inst Nacl Med Genom, Direcc Gen, Mexico City 14610, DF, Mexico

[15] Inst Nacl Neurol & Neurocirugia Manuel Velasco Su, Lab Clin Enfermedades Neurodegenerat, Mexico City 14269, DF, Mexico

来源：

CELLULAR AND MOLECULAR NEUROBIOLOGY | 2021年 / 41卷 / 06期

关键词：

Astrocytoma; Germline genetic variant; Risk; Mexican population; TUMOR-GROWTH; RISK; ANGIOTENSINOGEN; ASSOCIATION; EXPRESSION; SYSTEM; POLYMORPHISMS; ANGIOGENESIS; METHYLATION; RS78378222;

D O I：

10.1007/s10571-020-00901-7

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Astrocytoma is the most common type of primary brain tumor. The risk factors for astrocytoma are poorly understood; however, germline genetic variants account for 25% of the risk of developing gliomas. In this study, we assessed the risk of astrocytoma associated with variants inAGT, known by its role in angiogenesis,TP53, a well-known tumor suppressor and the DNA repair geneMGMTin a Mexican population. A case-control study was performed in 49 adult Mexican patients with grade II-IV astrocytoma. Sequencing of exons and untranslated regions ofAGT,MGMT, andTP53from was carried in an Ion Torrent platform. Individuals with Mexican Ancestry from the 1000 Genomes Project were used as controls. Variants found in our cohort were then assessed in a The Cancer Genome Atlas astrocytoma pan-ethnic validation cohort. Variants rs1926723 located inAGT(OR 2.74, 1.40-5.36 95% CI), rs7896488 inMGMT(OR 3.43, 1.17-10.10 95% CI), and rs4968187 inTP53(OR 2.48, 1.26-4.88 95% CI) were significantly associated with the risk of astrocytoma after multiple-testing correction. This is the first study where theAGTrs1926723 variant,TP53rs4968187, andMGMTrs7896488 were found to be associated with the risk of developing an astrocytoma.

引用

页码：1285 / 1297

页数：13

共 50 条

[31] Prevalence of germline mutations in the TP53 gene in patients with early-onset breast cancer in the Mexican population
Gallardo-Alvarado, Lenny N.
Teresa Tusie-Luna, Maria
Isabel Tussie-Luna, Maria
Diaz-Chavez, Jose
Segura, Yayoi X.
Bargallo-Rocha, Enrique
Villarreal, Cynthia
Herrera-Montalvo, Luis A.
Herrera-Medina, Enrique M.
Cantu-de Leon, David F.
BMC CANCER, 2019, 19 (1)
[32] Cancer risk in carriers of TP53 germline variants grouped into different functional categories
Muentnich, Lucas John
Dutzmann, Christina M.
Grosshennig, Anika
Haerter, Valentina
Keymling, Myriam
Mastronuzzi, Angela
Montellier, Emilie
Nees, Juliane
Palmaers, Natalie E.
Penkert, Judith
Pfister, Stefan M.
Ripperger, Tim
Schott, Sarah
Silchmueller, Farina
Hainaut, Pierre
Kratz, Christian P.
JNCI CANCER SPECTRUM, 2025, 9 (01)
[33] TP53 germline mutations in Portugal and genetic modifiers of age at cancer onset
Pinto, Carla
Veiga, Isabel
Pinheiro, Manuela
Peixoto, Ana
Pinto, Armando
Lopes, Jose M.
Reis, Rui M.
Oliveira, Carla
Baptista, Manuela
Roque, Lucia
Regateiro, Fernando
Cirnes, Luis
Hofstra, Robert M. W.
Seruca, Raquel
Castedo, Sergio
Teixeira, Manuel R.
FAMILIAL CANCER, 2009, 8 (04) : 383 - 390
[34] Risk of therapy-related subsequent cancers in individuals with germline TP53 variants
Villani, Anita
Khincha, Payal
Hatton, Jessica
Schonfeld, Sara
Goudie, Catherine
Oba, Leatrisse
Pithadia, Kishan
Sanger, Birte
Kratz, Christian
Le, Anh N.
Orr, Caitlin
Maxwell, Kara N.
Naumer, Anne
Vagher, Jennie
Kohlmann, Wendy
Schi, Joshua
dos Santos, Elizabeth Santana
Michaeli, Orli
Carson, Jacob J.
Tsang, Derek S.
Kim, Raymond
Maciaszek, Jamie L.
Nichols, Kim E.
Goodman, Victoria E.
MacFarland, Suzanne P.
Reichman, Lara
Achatz, Maria Isabel
Savage, Sharon
Malkin, David
Morton, Lindsay M.
CANCER RESEARCH, 2024, 84 (17)
[35] TP53 germline mutations in Portugal and genetic modifiers of age at cancer onset
Carla Pinto
Isabel Veiga
Manuela Pinheiro
Ana Peixoto
Armando Pinto
José M. Lopes
Rui M. Reis
Carla Oliveira
Manuela Baptista
Lúcia Roque
Fernando Regateiro
Luís Cirnes
Robert M. W. Hofstra
Raquel Seruca
Sérgio Castedo
Manuel R. Teixeira
Familial Cancer, 2009, 8 : 383 - 390
[36] Drastic Effect of Germline TP53 Missense Mutations in LiFraumeni Patients
Zerdoumi, Yasmine
Aury-Landas, Juliette
Bonaiti-Pellie, Catherine
Derambure, Celine
Sesbouee, Richard
Renaux-Petel, Mariette
Frebourg, Thierry
Bougeard, Gaelle
Flaman, Jean-Michel
HUMAN MUTATION, 2013, 34 (03) : 453 - 461
[37] Cutaneous pleomorphic fibromas arising in patients with germline TP53 mutations
Cloutier, Jeffrey M.
Shalin, Sara C.
Lindberg, Matthew
Gardner, Jerad M.
Fernandez-Pol, Sebastian
Zaba, Lisa
Novoa, Roberto
Brown, Ryanne A.
JOURNAL OF CUTANEOUS PATHOLOGY, 2020, 47 (08) : 734 - 741
[38] Risk of Radiation -Associated Secondary Malignancies among Patients with Breast Cancer Harboring TP53 Germline Variants
Cederquist, G.
Boe, L.
Walsh, M. F.
Stadler, Z.
Xu, A. J.
Mueller, B. A.
O'Brien, D. A. Roth
Bernstein, M. B.
Cuaron, J.
Bakhoum, S. F.
Powell, S. N.
Khan, A. J.
Robson, M. E.
Maxwell, K.
Taunk, N. K.
Braunstein, L. Z.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S45 - S46
[39] TP53 MUTATIONS IN CODON 273 IS PREDICTIVE OF OVERALL SURVIVAL IN ASTROCYTOMA PATIENTS
Noor, H.
Rapkins, R.
McDonald, K.
NEURO-ONCOLOGY, 2019, 21 : 32 - 32
[40] Genetic Characteristics of EGFR Concurrent Variants with RB1 and TP53 in NCSLC Patients
Chen, H.
Yuan, S.
Chen, L.
Shi, X.
Wang, L.
Dong, X.
Wang, M.
Wang, A.
Liu, W.
Cui, Z.
Chen, C.
Mei, L.
JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S587 - S588

← 1 2 3 4 5 →